Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |